文献速递糖尿病性腺与生殖内分泌

血糖控制与成年身高:一项关于儿童1型糖尿病的瑞典全国队列研究

Glycemic Control and Adult Height: A Nationwide Swedish Cohort Study on Childhood Type 1 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

该研究基于瑞典全国糖尿病登记库,纳入儿童期起病的1型糖尿病患者的专科随访数据,比较血糖控制欠佳(HbA1c 53-75 mmol/mol)和差(HbA1c >75 mmol/mol)与最佳控制(HbA1c <53 mmol/mol)对成年最终身高和矮身材风险的影响。结果显示,血糖控制差与男性成年身高降低及矮身材风险升高相关,女性仅在青春期前起病且青春期前血糖控制差时成年身高降低。

要点

  • 血糖控制差(HbA1c >75 mmol/mol)与男性成年身高降低2.91 cm相关,女性降低1.83 cm。
  • 血糖控制差与男性矮身材风险升高相关(OR 1.90),女性无显著关联(OR 0.73)。
  • 女性青春期前血糖控制差对成年身高的影响较男性更关键。

核心结论

  • 与最佳血糖控制相比,1型糖尿病起病后血糖控制差与男性和女性成年身高降低相关。
  • 青春期前时期对女性的影响似乎比男性更关键。

研究设计与样本

  • 基于瑞典全国糖尿病登记库的全国性队列研究,纳入所有儿童期起病的1型糖尿病患者,收集专科医疗访视中的血糖控制和身高数据。
  • 采用线性回归和逻辑回归,比较血糖控制欠佳(HbA1c 53-75 mmol/mol [7.0-9.0%])和差(HbA1c >75 mmol/mol [>9.0%])与最佳控制(HbA1c <53 mmol/mol [<7.0%])对成年最终身高和矮身材风险的影响。

主要发现

  • 血糖控制差与男性成年身高降低2.91 cm(95% CI,-3.48至-2.33)相关,与女性降低1.83 cm(95% CI,-2.42至-1.23)相关。
  • 血糖控制差与男性矮身材风险升高相关(OR 1.90 [95% CI,1.07-3.35]),与女性矮身材风险无显著关联(OR 0.73 [95% CI,0.36-1.51])。
  • 女性中,仅青春期前起病且血糖控制差发生在青春期前时成年身高才降低。
  • 男性中,无论糖尿病起病年龄如何,只要在青春期或青春期后血糖控制差,成年身高即降低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Normal growth throughout childhood and adolescence is considered an indicator of adequate glycaemic control in patients with type 1 diabetes. While it has been suggested that growth in type 1 diabetes is reduced, the literature is conflicting and differences in final adult height and the risk of short stature depending on glycaemic control remain largely unexplored. OBJECTIVE: This work aims to assess adult height outcomes across levels of glycemic control in children and adolescents with type 1 diabetes, as well as to investigate the effect of sex, age at disease onset, and timing of glycemic control in relation to puberty. METHODS: In this population-based Swedish cohort study, we collected data on glycemic control and height from specialist health-care visits of all individuals with childhood-onset type 1 diabetes in the National Diabetes Register. Using linear and logistic regression, we compared suboptimal (glycated hemoglobin A1c [HbA1c] 53-75 mmol/mol [7.0-9.0%]) and poor (HbA1c > 75 mmol/mol [>9.0%]) to optimal (HbA1c < 53 mmol/mol [<7.0%]) glycemic control in relation to final adult height and the risk of short stature. RESULTS: Poor glycemic control was associated with lower final adult height (-2.91 cm [95% CI, -3.48 to -2.33] for males, -1.83 cm [-2.42 to -1.23] for females) as well as a higher risk of short stature in males (odds ratio 1.90 [1.07-3.35]) but not in females (0.73 [0.36-1.51]). For females, adult height was lower only among those with type 1 diabetes since before puberty and if the poor glycemic control occurred before puberty. For males, adult height was lower irrespective of their age at diabetes onset, but only if they had poor glycemic control during or after puberty. CONCLUSION: Poor glycemic control after the onset of type 1 diabetes, compared to optimal control, is associated with lower adult height in males and females. The prepubertal period seems to be more critical for females than males.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Smew AI, Lundholm C, Gong T, et al. Glycemic Control and Adult Height: A Nationwide Swedish Cohort Study on Childhood Type 1 Diabetes. J Clin Endocrinol Metab. 2025. PMID: 39556501. doi:10.1210/clinem/dgae809

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。